Emerging therapeutic strategies for drug-sensitive tuberculosis
Annals of the National Academy of Medical Sciences (India) · 04.11.2026 · 1-5
DOI: 10.25259/anams_14_2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the National Academy of Medical Sciences (India), online erschienen am 04.11.2026. Verfasst von Rajendra Prasad und 3 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Tuberculosis (TB) remains a leading cause of global morbidity and mortality despite sustained international control efforts. Over the past decade, the management of TB has evolved, with treatment strategies now broadly categorized into drug-sensitive tuberculosis (DS-TB) and drug-resistant tuberculosis (DR-TB). While the standard six-month regimen for DS-TB has remained largely unchanged, recent years have witnessed significant advances, including the introduction of shorter regimens and updated international guideline recommendations. This review summarizes contemporary evidence and updates in the treatment of DS-TB, with emphasis on World Health Organization (WHO) recommendations, national programmatic adaptations, and emerging therapeutic strategies.
Zitieren
APA
Prasad, R., Shamim, H., Gupta, N., & Singh, A. K. (2026). Emerging therapeutic strategies for drug-sensitive tuberculosis. Annals of the National Academy of Medical Sciences (India), 0, 1-5. https://doi.org/10.25259/anams_14_2026
Vancouver
Prasad R, Shamim H, Gupta N, Singh AK. Emerging therapeutic strategies for drug-sensitive tuberculosis. Annals of the National Academy of Medical Sciences (India). 2026;0:1-5. doi:10.25259/anams_14_2026
BibTeX
@article{Prasad2026,
author = {Prasad, Rajendra and Shamim, Huda and Gupta, Nikhil and Singh, Anil Kumar},
title = {Emerging therapeutic strategies for drug-sensitive tuberculosis},
journal = {Annals of the National Academy of Medical Sciences (India)},
year = {2026},
volume = {0},
pages = {1--5},
doi = {10.25259/anams_14_2026}
}
EUVIMED